Cargando…
Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world
BACKGROUND: The aim of the study was to assess the efficacy and side‐effects of intrapleural treatment in non‐small cell lung cancer (NSCLC) patients with malignant pleural effusions (MPEs). METHODS: The medical records of NSCLC patients with MPEs diagnosed in four Chinese hospitals from October 201...
Autores principales: | Pan, Pengfei, Wu, Fengjuan, Xu, Zhiyun, Ji, Xiang, Qi, Qian, Huang, Xiaomin, Zhao, Ruyue, Liu, Mingtao, Jiang, Peng, Li, Yu, Xu, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671907/ https://www.ncbi.nlm.nih.gov/pubmed/34741494 http://dx.doi.org/10.1111/1759-7714.14224 |
Ejemplares similares
-
Intrapleural combination therapy with lobaplatin and erythromycin for non‐small cell lung cancer‐mediated malignant pleural effusion
por: Xu, Lisheng, et al.
Publicado: (2018) -
Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
por: Moon, Youngkyu, et al.
Publicado: (2015) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021) -
Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
por: Foo, Chuan Tai, et al.
Publicado: (2021) -
Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion
por: Acencio, Milena Marques Pagliarelli, et al.
Publicado: (2017)